Nuevos horizontes en el tratamiento médico de la hidradenitis supurativa

• Patricia Garbayo-Salmons ^[1] ; Jorge Romaní de Gabriel ^[1]
  1. [1] Servicio de Dermatología, Hospital Universitario Parc Taulí, Sabadell, Barcelona, España
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 38, Nº. 3 (MARZO), 2023, págs. 155-158
• Idioma: español
• DOI: 10.1016/j.piel.2022.09.003
• Títulos paralelos:
  • New horizons in the medical treatment of hidradenitis suppurativa
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • Nguyen TV, Damiani G, Orenstein L, et al. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities...
  • Narla S, Azzam M, Townsend S, et al. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with...
  • Zouboulis CC, Benhadou F, Byrd AS, et al. What causes hidradenitis suppurativa?-15 years after. Exp Dermatol. 2020;29 (12):1154–1170.
  • Jfri AH, O’Brien EA, Litvinov IV, Alavi A, Netchiporouk E. Hidradenitis suppurativa: comprehensive review of predisposing genetic mutations...
  • Garbayo-Salmons P, Romaní J, Ferrer de la Fuente C, et al. Hidradenitis suppurative: our experience with a surgical case management team....
  • Tzellos T, Zouboulis CC. Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther (Heidelb)....
  • Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United...
  • Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol...
  • Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375(5):422–434.
  • Grant A, Gonzalez T, Montgomery MO, et al. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized,...
  • Wohlmuth-Wieser I, Alhusayen R. Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy. Int J Dermatol. 2021;60(4):e140–e141.
  • Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, et al. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis....
  • Casseres RG, Prussick L, Zancanaro P, et al. Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: results of an open-label...
  • Reguiaï Z, Fougerousse AC, Maccari F, et al. Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases). J Eur Acad...
  • Frew JW, Navrazhina K, Grand D, et al. The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An...
  • Frew JW, Navrazhina K, Sullivan-Whalen M, et al. Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study....
  • Glatt S, Jemec GBE, Forman S, et al. Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind,...
  • Kimball AB, Loesche C, Prens EP, et al. IL-17A is a pertinent therapeutic target for moderate to severe hidradenitis suppurativa: combined...
  • Blok JL, Li K, Brodmerkel C, et al. Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum....
  • Vossen ARJV, van Doorn MBA, van der Zee HH, et al. Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial....